Editor - Avraham Raz | Wayne State University | 18705
ISSN: 2572-5645

Advances in Molecular Diagnostics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Avraham Raz

Avraham Raz
Avraham Raz
Wayne State University
Wayne State University


I am the Paul Zuckerman Professor of Oncology and Pathology at Wayne State University, School of Medicine and Member of the NCI designated CCC. I have > 30 years of experience in cancer biology and have published numerous research articles and reviews summarizing my contributions to the field of tumor progression and metastasis, for which I have received a Merit Award, form the NCI. We were the first to clone Autocrine Motility Factor (AMF), A.K.A. Neuroleukin (NLK and Maturation Factor (MF), and reported that it is secreted in response to CKI phosphorylation and crystalized it show that it is a dimer and is a cytokine harboring the C-X-X-C motif. We were the first to show that human fibrosarcoma undergoes MET in response to AMF which is regulated by mir-200 and also is involved in EMT regulation of epithelial cancers We continue to identify its cell surface receptor, gp78/AMFR and reported it to be a transmembrane G-binding protein. We proceeded to clone it and reported that is it homologous to the yeast hrdl-1 HRD-Like (E3 ubiquitin ligase related), a finding which has open a flood gate of research. We have recently showed that AMF-gp78 are not only involved in signaling but that polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases.

Research Interest

Dr. Raz’s goal is to further the understanding of cancer progression and metastasis using in vitro and in vivo methodologies.

Global Speakers in the subject

Global Experts in the subject